India's HPV vaccine, Cervavac, faces delays for inclusion in immunization programs due to ongoing studies and competition ...
While new treatments like immunotherapy &minimally invasive surgeries offer hope, low awareness, limited screening, high costs continue to hinder early detection and effective care for women across ...
As the burden of cancer grows exponentially in India, Dr Shalini Singh, director of Indian Council of Medical Research-National Institute of Cancer Prevention a ...
This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.
BioAtla has engaged Tungsten Advisors as the Company’s exclusive strategic financial advisor. There can be no assurance that this process will result in any such transaction. BioAtla does not intend ...
Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...
INOVIO , and Akeso, Inc. (9926.HK) ("Akeso") today announced that they have entered into a clinical trial collaboration and supply agreement to evaluate INO-5412, INOVIO's DNA immunotherapy candidate, ...
Asieris Pharmaceuticals (Stock Code: 688176.SH), a global innovative pharmaceutical company focused on genitourinary tumors and women's health, announced today that its core product APL-1702 (trade ...
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the ...
Collaboration will evaluate INOVIO's INO-5412 (INO-5401 plus INO-9012) in combination with Akeso's cadonilimab as a potential treatment for glioblastoma (GBM), the most common and aggressive ...
Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...
This is less than a year after the Teal Wand from Teal Health became the first at-home cervical cancer screening test approved by the U.S. Food and Drug Administration.